Systemic scleroderma - Prognosis determined by internal manifestations;Die progressiv systemische sklerodermie - Prognosebestimmender befall innerer organsysteme

Hautarzt

Volumn 49, Issue 7, 1998, Pages 545-551

  Mittag, Matthias ^a   Haustein, Uwe Frithjof ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Involvement of internal organs; Prognosis; Systematic sclerosis

Indexed keywords

CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DISEASE COURSE; ESOPHAGUS MOTILITY; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART MUSCLE FIBROSIS; HUMAN; KIDNEY FAILURE; LUNG FIBROSIS; PERICARDIAL EFFUSION; PERICARDITIS; PROGNOSIS; PROTEINURIA; PULMONARY HYPERTENSION; REVIEW; SYSTEMIC SCLEROSIS; HEART DISEASE; KIDNEY DISEASE; LUNG DISEASE; MORTALITY; SURVIVAL RATE;

HEART DISEASES; HUMANS; KIDNEY DISEASES; LUNG DISEASES; PROGNOSIS; SCLERODERMA, SYSTEMIC; SURVIVAL RATE;

EID: 0031594934     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050786     Document Type: Review

References (40)

1. Abu-Shakra M, Lee P (1995) Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol 22:2100-2102
2. Akesson A, Scheja A, Lundin A, Wollheim F (1994) Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum 37:729-735
3. Alpert MA, Pressly TA, Mukerji V et al (1991) Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with systemic sclerosis, the CREST syndrome and mixed connective tissue disease. Am J Cardiol 68:1687-1691
4. Alpert MA, Pressly TA, Mukerji V et al (1992) Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease. Chest 102:1407-1412
5. Altman RD, Medsger T, Bloch AD, Beat AM (1991) Predictors of survival in systemic sclerosis. Arthritis Rheum 34:403-413
6. Alton E, Turner-Warwick M (1988) Lung involvement in scleroderma. In: Jayson MIV, Black CM (eds) Systemic sclerosis:scleroderma. John Wiley & Sons, Chichester, pp 181-205
7. Arbeitsgruppe Sklerodermie der Arbeitsgemeinschaft Dermatologische Forschung (ADF) (1986) Klinik der progressiven systemischen Sklerodermie (PSS). Hautarzt 37:320-324
8. Behr J, König G, Meurer M, Krieg T (1990) Pulmonale Manifestation bei progressiver systemischer Sklerodermie: Prognostische Wertigkeit der Zentromerantikörper und Antikörper gegen Scl-70-Nukleoprotein. Pneumologie 44:822-825
9. Blumenstein M, Sorodoc J, Weiss M (1997) Nierenbeteiligung bei progressiver Sklerodermie. Dtsch Med Wochenschr 122:200-204
10. Black CM, Denton CP (1995) The managment of systemic sclerosis. Br J Rheumatol 34:3-7
11. Breit SN, Thornton SC, Penny R (1994) Lung involvement in scleroderma. Clin Dermatol 12:243-252
12. Briggs DC, Vaughan RW, Welsh KI, Myers A, Du Bois RM, Black CM (1991) Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet 338:661-662
13. Bryan C, Howard Y, Brennan P, Black C, Silman A (1996) Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 35:1122-1126
14. Candell-Riera J, Armandans-Gil L, Simeon CP et al (1996) Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum 39:1138-1145
15. Chapman PJ, Pascoe MD, Van Zyl-Smit R (1986) Succesful use of captopril in the treatment of scleroderma renal crisis. Clin Nephrol 26:106-108
16. Clements PJ, Furst DE (1994) Heart involvement in systemic sclerosis. Clin Dermatol 12:267-275
17. D'Alonso, Barst RJ, Ayres SM et al (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Int Med 115:343-349
18. Rich S, Kaufman E, Levy PS (1992) The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med 327:76-81
19. Deswal A, Follansbee WP (1996) Cardiac involvement in scleroderma. Rheum Dis Clin North Am 22:841-860
20. Haustein UF, Albrecht M (1993) Zur Epidemiologie und Klinik der systemischen Sklerodermie. H+G 68:651-658
21. Haustein UF (1975) Elektronenmikroskopische Untersuchungen zur Nierenbeteiligung bei der progressiven Sklerodermie. Derm Monatsschr 161:22-31
22. Haustein UF (1976) Das Gefäßsystem bei der progressiven Sklerodermie. Derm Monatsschr 162:721-725
23. Hegedus I, Czirjak L (1995) Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis. Clin Rheumatol 14:161f
24. König G (1996) Die pulmonale Manifestation der Sklerodermie. Akt Rheumatol 21:190-196
25. Lee P, Langevitz P, Alderdice CA, Aubrey M et al (1992) Mortality in systemic sclerosis (scleroderma). Q J Med 298:139-148
26. Medsger TA Jr, Masi AT (1973) Survival with scleroderma-II: a life-table analysis of clinical and demographic factors in 358 male US veteran patients. J Chron Dis 26:647
27. Meurer M, Scharf A, Luderschmidt CH, Braun-Falco O (1985) Zentromerantikörper und Antikörper gegen Scl-70-Nukleoprotein bei progressiver systemischer Sklerodermie. Dtsch Med Wochenschr 109:8-14
28. Okano Y (1996) Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 22:709-735
29. Perez MI, Kohn SR (1993) Systemic sclerosis. J Am Acad Dermatol 28:525-547
30. Silver RM (1991) Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis 50:846-853
31. Silver RM, Miller KS, Kinsella MB, Smith EA, Schabel SI (1990) Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 88:470-476
32. Silver RM, Warrick JH, Kinsella MB, Staudt LS, Baumann MH, Strange C (1993) Cyclophophamide and low-dose prednisone therapie in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheum 20:838-844
33. Steen VD (1996) Scleroderma renal crisis. Rheum Dis Clin North Am 22:861-878
34. Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA (1985) Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 28:759-767
35. Steen VD, Conte C, Owens GR, Medsger TA (1994) Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37:1283-1289
36. Steen VD, Costantino JP, Shapiro AP et al (1990) Outcome of renal crisis in systemic sclerosis. Ann Int Med 113:352-357
37. Steen VD, Medsger TA, Osial TA, Ziegler GL, Shapiro AP Rodnan GP (1984) Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76:779-786
38. Sollberg S, Krieg T (1995) Systemische Sklerodermie. Hautarzt 46:587-601
39. Thornten SC, Robbins JM, Shelley L et al (1992) Fibroblast growth factors in connective tissue disease associated interstitial lung disease: association with disease activity and identification as TNF-a, PDGF, and fibronectin. Clin Exp Immunol 90:447-452
40. Young MA, Rose S, Reynolds JC (1996) Gastrointestinal manifestation of scleroderma. Rheum Dis Clin North Am 22:797-823